187 related articles for article (PubMed ID: 17589924)
1. Comparison of three different recombinant hepatitis B vaccines: GeneVac-B, Engerix B and Shanvac B in high risk infants born to HBsAg positive mothers in India.
Velu V; Nandakumar S; Shanmugam S; Jadhav SS; Kulkarni PS; Thyagarajan SP
World J Gastroenterol; 2007 Jun; 13(22):3084-9. PubMed ID: 17589924
[TBL] [Abstract][Full Text] [Related]
2. Hepatitis B vaccination of premature infants: a reassessment of current recommendations for delayed immunization.
Losonsky GA; Wasserman SS; Stephens I; Mahoney F; Armstrong P; Gumpper K; Dulkerian S; West DJ; Gewolb IH
Pediatrics; 1999 Feb; 103(2):E14. PubMed ID: 9925860
[TBL] [Abstract][Full Text] [Related]
3. Safety and immunogenicity of a novel mammalian cell-derived recombinant hepatitis B vaccine containing Pre-S1 and Pre-S2 antigens in children.
Raz R; Dagan R; Gallil A; Brill G; Kassis I; Koren R
Vaccine; 1996 Feb; 14(3):207-11. PubMed ID: 8920701
[TBL] [Abstract][Full Text] [Related]
4. An efficacy trial of a mammalian cell-derived recombinant DNA hepatitis B vaccine in infants born to mothers positive for HBsAg, in Shanghai, China.
Halliday ML; Kang LY; Rankin JG; Coates RA; Corey PN; Hu ZH; Zhou TK; Yuan GJ; Yao FL
Int J Epidemiol; 1992 Jun; 21(3):564-73. PubMed ID: 1386063
[TBL] [Abstract][Full Text] [Related]
5. Hepatitis B immunization in high risk neonates born from HBsAg positive mothers: comparison between plasma derived and recombinant DNA vaccine.
Pongpipat D; Suvatte V; Assateerawatts A
Asian Pac J Allergy Immunol; 1989 Jun; 7(1):37-40. PubMed ID: 2526633
[TBL] [Abstract][Full Text] [Related]
6. Immunogenicity and protective efficacy of low dose recombinant DNA hepatitis B vaccine in normal and high-risk neonates.
Assateerawatt A; Tanphaichitr VS; Suvatte V; In-ngarm L
Asian Pac J Allergy Immunol; 1991 Dec; 9(2):89-93. PubMed ID: 1839654
[TBL] [Abstract][Full Text] [Related]
7. The safety and immunogenicity of a recombinant hepatitis B vaccine in neonates.
Gunn TR; Bosley A; Woodfield DG
N Z Med J; 1989 Jan; 102(860):1-3. PubMed ID: 2521527
[TBL] [Abstract][Full Text] [Related]
8. Comparative study of the immunogenicity and safety of two dosing schedules of hepatitis B vaccine in neonates.
Bassily S; Kotkat A; Gray G; Hyams KC; Brown FM; Imam IZ; Arthur R
Am J Trop Med Hyg; 1995 Oct; 53(4):419-22. PubMed ID: 7485697
[TBL] [Abstract][Full Text] [Related]
9. Protective effect of hepatitis B vaccine combined with two-dose hepatitis B immunoglobulin on infants born to HBsAg-positive mothers.
Zou H; Chen Y; Duan Z; Zhang H
PLoS One; 2011; 6(10):e26748. PubMed ID: 22053208
[TBL] [Abstract][Full Text] [Related]
10. Safety and immunogenicity of indigenous recombinant hepatitis B vaccine (Shanvac-B) in comparison with commercially available vaccine.
Joshi N; Kumar A; Sreenivas DV; Palan S; Nagarjuna Kumar YR
Indian J Gastroenterol; 2000; 19(2):71-3. PubMed ID: 10812819
[TBL] [Abstract][Full Text] [Related]
11. Comparison of the immune response of four different dosages of a yeast-recombinant hepatitis B vaccine in Singapore children: a four-year follow-up study.
Goh KT; Tan KL; Kong KH; Oon CJ; Chan SH
Bull World Health Organ; 1992; 70(2):233-9. PubMed ID: 1600584
[TBL] [Abstract][Full Text] [Related]
12. Safety and immunogenicity of a novel mammalian cell-derived recombinant hepatitis B vaccine containing Pre-S1 and Pre-S2 antigens in neonates.
Yerushalmi B; Raz R; Blondheim O; Shumov E; Koren R; Dagan R
Pediatr Infect Dis J; 1997 Jun; 16(6):587-92. PubMed ID: 9194109
[TBL] [Abstract][Full Text] [Related]
13. Results of vaccinated infants born to HBsAg-positive mothers with different hepatitis B vaccines and doses.
Kuru U; Turan O; Kuru N; Sağlam Z; Alver A
Turk J Pediatr; 1995; 37(2):93-102. PubMed ID: 7597774
[TBL] [Abstract][Full Text] [Related]
14. Long-term immunogenicity and efficacy of hepatitis B vaccine in infants born to HBeAg-positive HBsAg-carrier mothers.
Lo KJ; Lee SD; Tsai YT; Wu TC; Chan CY; Chen GH; Yeh CL
Hepatology; 1988; 8(6):1647-50. PubMed ID: 3192179
[TBL] [Abstract][Full Text] [Related]
15. The protective efficacy of recombinant hepatitis B vaccine in newborn infants of hepatitis B e antigen-positive-hepatitis B surface antigen carrier mothers.
Lee CY; Huang LM; Chang MH; Hsu CY; Wu SJ; Sung JL; Safary A
Pediatr Infect Dis J; 1991 Apr; 10(4):299-303. PubMed ID: 1829515
[TBL] [Abstract][Full Text] [Related]
16. Hepatitis B vaccination in preterm infants.
Gołebiowska M; Kardas-Sobantka D; Chlebna-Sokół D; Sabanty W
Eur J Pediatr; 1999 Apr; 158(4):293-7. PubMed ID: 10206126
[TBL] [Abstract][Full Text] [Related]
17. Comparative safety and immunogenicity of two recombinant hepatitis B vaccines given to infants at two, four and six months of age.
Greenberg DP; Vadheim CM; Wong VK; Marcy SM; Partridge S; Greene T; Chiu CY; Margolis HS; Ward JI
Pediatr Infect Dis J; 1996 Jul; 15(7):590-6. PubMed ID: 8823852
[TBL] [Abstract][Full Text] [Related]
18. Failure of neonatal hepatitis B vaccination: the role of HBV-DNA levels in hepatitis B carrier mothers and HLA antigens in neonates.
del Canho R; Grosheide PM; Schalm SW; de Vries RR; Heijtink RA
J Hepatol; 1994 Apr; 20(4):483-6. PubMed ID: 8051386
[TBL] [Abstract][Full Text] [Related]
19. Immunogenicity and safety in newborns of a new recombinant hepatitis B vaccine containing the S and pre-S2 antigens.
Soulié JC; Devillier P; Santarelli J; Goudeau A; Vermeulen P; Guellier M; Saliou P; Hillion AM; Tron F; Huchet J
Vaccine; 1991 Aug; 9(8):545-8. PubMed ID: 1837646
[TBL] [Abstract][Full Text] [Related]
20. Hepatitis B immunization in high risk neonates born from HBsAg and HBeAg positive mothers: comparison of standard and low dose regimens.
Pongpipat D; Suvatte V; Assateerawatts A
Asian Pac J Allergy Immunol; 1988 Dec; 6(2):107-10. PubMed ID: 2975491
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
